Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Tsuji

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Journal of Clinical Medicine|November 3, 2020
Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening EndoscopyKoji Ishida, Tadashi Namisaki, Koji Murata, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Hemoglobin and Endotoxin Levels Predict Sarcopenia Occurrence in Patients with Alcoholic CirrhosisAkihiko Shibamoto, Tadashi Namisaki, Junya Suzuki, et al.
International Journal of Molecular Sciences|March 13, 2024
ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver CirrhosisJunya Suzuki, Tadashi Namisaki, Hiroaki Takya, et al.
Hepatology Communications|February 7, 2018
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosisTadashi Namisaki, Kei Moriya, Mitsuteru Kitade, et al.
Medicine|September 13, 2021
The association between sarcopenia and endotoxin in patients with alcoholic cirrhosisShinya Sato, Tadashi Namisaki, Koji Murata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 11, 2018
Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosisYasushi Okura, Tadashi Namisaki, Shinya Sato, et al.
Experimental and Therapeutic Medicine|September 14, 2018
Efficacy and tolerability of interferon-free regimen for patients with genotype-1 HCV infectionKosuke Takeda, Ryuichi Noguchi, Tadashi Namisaki, et al.
DEN Open|October 28, 2022
Diagnostic yield of liquid-based cytology in serial pancreatic juice aspiration cytological examinationKoh Kitagawa, Akira Mitoro, Fumimasa Tomooka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 26, 2019
Identification of clinical risk factors for histological progression of primary biliary cholangitisYukihisa Fujinaga, Tadashi Namisaki, Kei Moriya, et al.
Medicine|October 1, 2021
Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitisYukihisa Fujinaga, Tadashi Namisaki, Hiroaki Takaya, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Journal of Clinical Medicine|November 3, 2020
Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening EndoscopyKoji Ishida, Tadashi Namisaki, Koji Murata, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Hemoglobin and Endotoxin Levels Predict Sarcopenia Occurrence in Patients with Alcoholic CirrhosisAkihiko Shibamoto, Tadashi Namisaki, Junya Suzuki, et al.
International Journal of Molecular Sciences|March 13, 2024
ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver CirrhosisJunya Suzuki, Tadashi Namisaki, Hiroaki Takya, et al.
Hepatology Communications|February 7, 2018
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosisTadashi Namisaki, Kei Moriya, Mitsuteru Kitade, et al.
Medicine|September 13, 2021
The association between sarcopenia and endotoxin in patients with alcoholic cirrhosisShinya Sato, Tadashi Namisaki, Koji Murata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 11, 2018
Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosisYasushi Okura, Tadashi Namisaki, Shinya Sato, et al.
Experimental and Therapeutic Medicine|September 14, 2018
Efficacy and tolerability of interferon-free regimen for patients with genotype-1 HCV infectionKosuke Takeda, Ryuichi Noguchi, Tadashi Namisaki, et al.
DEN Open|October 28, 2022
Diagnostic yield of liquid-based cytology in serial pancreatic juice aspiration cytological examinationKoh Kitagawa, Akira Mitoro, Fumimasa Tomooka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 26, 2019
Identification of clinical risk factors for histological progression of primary biliary cholangitisYukihisa Fujinaga, Tadashi Namisaki, Kei Moriya, et al.
Medicine|October 1, 2021
Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitisYukihisa Fujinaga, Tadashi Namisaki, Hiroaki Takaya, et al.
Pageof 11